These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 28326838

  • 1. CTLA-4 gene polymorphisms associate with efficacy of postoperative radioiodine-131 for differentiated thyroid carcinoma.
    Chang DF, Chen XH, Huang J, Sun YM, Zhu DY, Xu ZQ.
    Future Oncol; 2017 May; 13(12):1057-1068. PubMed ID: 28326838
    [Abstract] [Full Text] [Related]

  • 2. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
    Abtahi S, Izadi Jahromi F, Dabbaghmanesh MH, Malekzadeh M, Ghaderi A.
    Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
    [Abstract] [Full Text] [Related]

  • 3. Association between CTLA-4 gene polymorphism and ankylosing spondylitis: a case-control study.
    Wang NG, Wang DC, Tan BY, Wang F, Yuan ZN.
    Int J Clin Exp Pathol; 2015 Oct; 8(6):7421-5. PubMed ID: 26261646
    [Abstract] [Full Text] [Related]

  • 4. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.
    Gunesacar R, Erken E, Dinkci S.
    Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220
    [Abstract] [Full Text] [Related]

  • 5. [Association of CTLA-4 gene polymorphisms with the genetic susceptibility and prognosis of patients with Bladder urothelial carcinoma].
    Li J, Zhang L, Xie H, Ge Y, Wang L.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Aug 10; 41(8):988-993. PubMed ID: 39097285
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D receptor polymorphisms associate with the efficacy and toxicity of radioiodine-131 therapy in patients with differentiated thyroid cancer.
    Deng Y, Fu Y, Feng G, Zhang Y.
    Cancer Biomark; 2024 Aug 10; 41(2):133-143. PubMed ID: 39302355
    [Abstract] [Full Text] [Related]

  • 7. The influence of CTLA-4 single nucleotide polymorphisms on acute kidney allograft rejection in Turkish patients.
    Ruhi Ç, Sallakçi N, Yeğin O, Süleymanlar G, Ersoy FF.
    Clin Transplant; 2015 Jul 10; 29(7):612-8. PubMed ID: 25981560
    [Abstract] [Full Text] [Related]

  • 8. Association of Cytotoxic T Lymphocyte Antigen-4 Gene Polymorphisms with Psoriasis Vulgaris: A Case-Control Study in Turkish Population.
    Dursun HG, Yılmaz HO, Dursun R, Kulaksızoğlu S.
    J Immunol Res; 2018 Jul 10; 2018():1643906. PubMed ID: 29850619
    [Abstract] [Full Text] [Related]

  • 9. Functional genetic variants of CTLA-4 and risk of tobacco-related oral carcinoma in high-risk North Indian population.
    Bharti V, Mohanti BK, Das SN.
    Hum Immunol; 2013 Mar 10; 74(3):348-52. PubMed ID: 23246583
    [Abstract] [Full Text] [Related]

  • 10. CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis.
    Song B, Liu Y, Liu J, Song X, Wang Z, Wang M, Zhu Y, Han J.
    Respiration; 2011 Mar 10; 82(5):439-44. PubMed ID: 21832820
    [Abstract] [Full Text] [Related]

  • 11. CTLA-4 (+49A/G) and NOD2/CARD15 (N852S) polymorphisms with inflammatory bowel disease in Turkish patients.
    Budak Diler S, Yaraş S.
    Cell Mol Biol (Noisy-le-grand); 2018 Aug 30; 64(11):97-101. PubMed ID: 30213296
    [Abstract] [Full Text] [Related]

  • 12. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
    Misra MK, Kapoor R, Pandey SK, Sharma RK, Agrawal S.
    J Interferon Cytokine Res; 2014 Mar 30; 34(3):148-61. PubMed ID: 24313821
    [Abstract] [Full Text] [Related]

  • 13. Association of CTLA-4 and CD28 Gene Polymorphisms with Type 1 Diabetes in South Indian Population.
    Gunavathy N, Asirvatham A, Chitra A, Jayalakshmi M.
    Immunol Invest; 2019 Aug 30; 48(6):659-671. PubMed ID: 31094250
    [Abstract] [Full Text] [Related]

  • 14. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
    Karabon L, Pawlak E, Tomkiewicz A, Jedynak A, Passowicz-Muszynska E, Zajda K, Jonkisz A, Jankowska R, Krzakowski M, Frydecka I.
    Hum Immunol; 2011 Oct 30; 72(10):947-54. PubMed ID: 21669243
    [Abstract] [Full Text] [Related]

  • 15. 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease.
    Bicek A, Zaletel K, Gaberscek S, Pirnat E, Krhin B, Stopar TG, Hojker S.
    Hum Immunol; 2009 Oct 30; 70(10):820-4. PubMed ID: 19559744
    [Abstract] [Full Text] [Related]

  • 16. Influence of cytotoxic T-lymphocyte antigen-4 polymorphisms on acute rejection onset of cadaveric renal transplants.
    Canossi A, Aureli A, Delreno F, Iesari S, Cervelli C, Clemente K, Famulari A, Pisani F, Papola F.
    Transplant Proc; 2013 Sep 30; 45(7):2645-9. PubMed ID: 24034013
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxic T lymphocyte antigen 4 (CTLA4) gene polymorphism with bladder cancer risk in North Indian population.
    Jaiswal PK, Singh V, Mittal RD.
    Mol Biol Rep; 2014 Feb 30; 41(2):799-807. PubMed ID: 24390231
    [Abstract] [Full Text] [Related]

  • 18. Association of CTLA-4 +49 A/G and CT60 Gene Polymorphism with Graves' Disease.
    Fouad NA, Saeed AM, Mahedy AW.
    Egypt J Immunol; 2017 Jun 30; 24(2):63-70. PubMed ID: 29528580
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
    Liu Y, He Z, Feng D, Shi G, Gao R, Wu X, Song W, Yuan W.
    DNA Cell Biol; 2011 Dec 30; 30(12):1051-5. PubMed ID: 21612409
    [Abstract] [Full Text] [Related]

  • 20. CTLA-4 SNPs (CT60A/G, -1722T/C, -1661G/A, and -318C/T) and systemic lupus erythematosus: a meta-analysis.
    Zhu Y, Wang J, Feng X.
    Crit Rev Eukaryot Gene Expr; 2014 Dec 30; 24(2):89-100. PubMed ID: 24940764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.